Voloridge Investment Management’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,375
Closed -$228K 1458
2023
Q2
$228K Sell
3,375
-9,579
-74% -$3.96M ﹤0.01% 1309
2023
Q1
$6.04M Buy
+12,954
New +$6.85M 0.03% 618
2022
Q4
Sell
-6,416
Closed -$2.09M 1499
2022
Q3
$2.09M Sell
6,416
-8,529
-57% -$2.75M 0.01% 975
2022
Q2
$3.94M Buy
14,945
+338
+2% +$86.4K 0.02% 766
2022
Q1
$4.39M Sell
14,607
-758
-5% -$264K 0.02% 681
2021
Q4
$5.42M Sell
15,365
-17,528
-53% -$5.46M 0.03% 699
2021
Q3
$8.4M Buy
32,893
+22,797
+226% +$8.08M 0.05% 491
2021
Q2
$6.72M Buy
+10,096
New +$5.82M 0.05% 534
2020
Q3
Sell
-1,233
Closed -$1.25M 1319
2020
Q2
$1.25M Buy
+1,233
New +$1.14M 0.01% 777
2020
Q1
Sell
-556
Closed -$596K 1185
2019
Q4
$596K Buy
+556
New +$568K 0.01% 779
2018
Q1
Sell
-582
Closed -$690K 543
2017
Q4
$690K Sell
582
-2,113
-78% -$2.65M 0.02% 395
2017
Q3
$3.63M Buy
+2,695
New +$2.84M 0.08% 223

Other funds holding KYNB

Voloridge Investment Management's KYNB Position: Q3 2023 in Review

Voloridge Investment Management sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 3,375 shares — an estimated $228K sold.

Voloridge Investment Management first reported a position in KYNB in Q3 2017 and held it in 12 quarters. The position peaked at $8.4M in Q3 2021. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Voloridge Investment Management reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 3,375 Kyntra Bio shares in Q3 2023, an estimated $228K.
  • Voloridge Investment Management first reported a position in Kyntra Bio in Q3 2017 and held it in 12 quarters.
  • Voloridge Investment Management's Kyntra Bio position peaked at $8.4M in Q3 2021.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Voloridge Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.